Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients
- Carol Milligan
- , Nazem Atassi
- , Suma Babu
- , Richard J. Barohn
- , James B. Caress
- , Merit E. Cudkowicz
- , Armineuza Evora
- , Gregory A. Hawkins
- , Marlena Wosiski-Kuhn
- , Eric A. Macklin
- , Jeremy M. Shefner
- , Zachary Simmons
- , Robert P. Bowser
- , Shafeeq S. Ladha
Research output: Contribution to journal › Article › peer-review
38
Link opens in a new tab
Scopus
citations